Pfizer, BioNTech team up with Brazil’s Eurofarma to make COVID-19 vaccine for Latin America

Seeking Alpha2021-08-26

Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have signeda letter of intent with Brazil-based Eurofarma Laboratórios SA, to manufacture its mRNACOVID-19 vaccine, COMIRNATY for distribution within Latin America.

Eurofarma will obtain drug product drug product from the U.S., and will perform manufacturing activities, with distribution expected to start in 2022.

Pfizer-BioNTech's COVID-19 vaccine supply chain and manufacturing network will now span four continents and include more than 20 manufacturing facilities.

At full operational capacity, the annual production is expected to exceed 100M finished doses annually. All doses will exclusively be distributed within Latin America.

To date, Pfizer and BioNTech have shipped more than 1.3B COVID-19 vaccine doses to more than 120 countries and territories.

Recently, Pfizer/BioNTech started rolling submission for FDA approval of booster COVID-19 shot.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
5